US Stock MarketDetailed Quotes
NAVB Navidea Biopharmaceuticals
- 0.000
- 0.0000.00%
15min DelayClose Dec 20 16:00 ET
10.01KMarket Cap0.00P/E (TTM)
0.000High0.000Low37.47KVolume0.000Open0.000Pre Close3.75Turnover0.06%Turnover Ratio0.00P/E (Static)100.08MShares0.13052wk High0.00P/B6.78KFloat Cap0.00052wk Low--Dividend TTM67.83MShs Float365.000Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low0.000Avg Price1Lot Size
About Navidea Biopharmaceuticals Company
Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.
Company Profile
SymbolNAVB
Company NameNavidea Biopharmaceuticals
Listing DateFeb 10, 2011
Issue Price6.00
Founded1983
CEODr. Michael S. Rosol, PhD
MarketPink Market
Employees15
Fiscal Year Ends12-31
Address4995 Bradenton Avenue,Suite 240
CityDublin
ProvinceOhio
CountryUnited States of America
Zip Code43017-3552
Phone1-614-793-7500
Websitehttp://www.navidea.com
Company Executives
- Name
- Position
- Salary
- Craig Dais
- Chief Financial Officer and Principal Accounting Officer
- --
- John K. Scott, Jr
- Vice Chairman of the Board
- 110.15K
- Dr. Jill Bieker Stefanelli, PhD
- Director
- --
- Joshua M. Wilson
- Director
- 17.72K
- Dana J. Moss, J.D.
- Director
- --
Heat List
US
Overall
Symbol
Price
% Chg
No Data